Professional Documents
Culture Documents
ნეიროდეგენერაციული დაავადებები
ნეიროდეგენერაციული დაავადებები
d v de e
daavadebebi
daunis
d u sindromi
d
II
farmakoTerapiuli samizmeebis gamoyeneba
molekuluri meqanizmebis darRvevisas
Ts65Dn
T 65D virTagvebSi
r bS CCatarebulia
r b kvlevebi,
b r romelic
m
mimarTulia mexsierebis gaumjobisebisken Semdegi gzebis
darRvevebis Tavidan acilebis gziT
http://www.youtube.com/watch?v=ocSptPUBbuo&feature=related
serotoninis efeqti unda regulirdebides S100B
cilis saSualebiTac
maT Soris vl
vlindeba
de urTierTreci
u e ec prokuli
kul kavSiri
k v
kerZod:
serotonini (5-HT1A
receptorebis saSualebiT)
ganapirobebs ujredidan
S100B–is gamoaTavisuflebas,
g v ufle
Tavis mxriv:
S100B ganapirobebs
serotoninis terminalebis
ganviTarebas
proteqtuli toqsiuri
qs r
da da
trofikuli
t f kul proapoptozuri
Tviseba Tvisebis
• NMDA receptorebTan,
• GABA-ergul receptorebTan
• dofaminergul receptorebTan
d
ds-iT davadebulebi,
d v de ule
iseve rogorc Ts65Dn virTagvebi
dsku-Si Seicaven genebs,
romlebis asinTezireben
kkalcineurinis
lc eu mainhibirebel
e el
cilebs
bs
2. sumoilirebiT,
u l e , -
xorcieldeba HSA21qromosomis
erTerTi genis produqtiT
SUMO3-iT (small ubiquitin like modifier protein 3),
(SUMO3-is
SUMO3 s trisomiac
r s m ar
r SeimCneva
S mCn T 65D virTagvebi
Ts65Dn r b )
gliis gliis
aqtivoba damokidebuli aqtovoba damokidebuli
neiroproteqtuli neiroproteqtuli
cila (adnc) faqtori (adnf)
NAP SAL
8 aminomJavuri naSTisgan 9 aminomJavuri naSTisgan
Semdgari peptidi Semdgari peptidi
ainhibirebs:
1. β-amiloidisN(Aβ) neirotoqsiurobas
2. amcirebs
c e neiroanTebiTi
e e procesebis
ce e siZlieres
l e e
s s neirodegeneraciis
ds-sas
ds n r n r s procesebs
pr s bs ZiriTadad
Z r
ganapirobebs oqsidaciuri stresis maRali done
• SOD1
• APP
• BACH1
• SOD1 -superoqsid dismutaza;
ROS-is (Jangbadis reqatiuli formebi) damazianebel moqmedebas zRudavs.
misi zeeqspresiisas SeimCneva mexsierebisa da daswavlis deficiti.
dauniT
d u d
daavadebul
v de ul Canasaxis tv
tvinSi misi W
Warbi raodenoba
de iwvevs
wvev
oqsidaciur stress
1. mexsierebas
2. daswavlis procesebs
(NMDA receptorze moqmedebis xarjze)
Tumca
u c piracetamis
cet analogiT
l g Ts65Dn vvirTagvebis
gve mkurnaloba
ku l
aranair dadebiT efeqts ar iZleva mexsierebis
gaumjobesebis TvalsazrisiT
problemebi samizneebis identificirebisa da
farmakoTerapiis preklinikuri Sefaseba
• s HSA21 genebis
dReisaTvis
s n b s Sesaxeb
S s x b informacia
n rm jer
r kidev
limitirebulia, umralevsi genTagani sruliad araa
Seswavlili
• f
farmakoTerapiisTvisYyvelaze
k e v yvel e did
d d problemad
le d rCeba
e
cxovelis srulyofili modelis SerCeva
gamosavali
g v l ?!
ZuZumwovrebis
u u w v e ujreduli
uj edul kultu
kulturebi
e gvTavazobs
gv v
am problemebis gadaWris rig SesaZleblobebs
SesaZleblobebs::
1. limfoblastoiduri ujreduli xazis
Seswavla, romelsac iReben ds-iT
daavadebuli pacientebisagan
dadebiTi:
misi kontroli SesaZlebelia
da molekuluri fenotipi
advilad Sesaswavli
uaryobiTi:
igi araa neironuli bunebis
limfoblastebi warmoadgenen
prekursor ujredebs moumwifebeli
limfocitebisaTvis
alternatiuli ujreduli xazis sistemad SeiZleba gamoviyenoT
ganviTarebadi Rerovani ujredebis xazi (iPS), romelsac iReben
genetikuri daavadebis mqone pacientebisagan
magaliTad rogoricaa:
• aqsonis ganviTareba,
• pasuxis
u siswrafe
w fe wamlis
w l moqmedebaze
q ede e
• am Tvisebebis cvlileba Sida individebis doneze
• wamliT mkurnalobis Sedegad, ds-is darRvevebis
koreqciis Sesabamisad iPS xazSi SegviZlia ganvsazRvroT
wamlis moqmedebis siZliere da SemdgomSi potenciurad
gamovikvlioT damatebiTi samizneebis arseboba
am anomaliebis ukeT SeswavlisaTvis darRvevebi unda iyos
Seswavlili aramarto genomur doneze da samizneebis
moqmedebis
q ede Sedegad
edeg d darRvevebis
d Rveve kkoreqciisken
eqc ke mimarTuli,
ul ,
aramed cilis donezec
es
s ukanaskneli
n s n moicavs
m s cilebis
b s modificirebas:
m r b s
1. fosforilirebas
2 acetilirebas
2.
3. sumoilizacias